This story first appeared in Adam’s Biotech Scorecard, a subscriber-only publication. STAT+ subscribers can join right here to get it delivered to their inbox.
I used to be a bit apprehensive final week’s angst-y rant on the grim state of biotech investing would flip people off. In actual fact, it was my hottest publication ever, with the model posted to STAT’s web site delivering a ton of latest subscribers. Thanks!
Why did “Biotech is in a darkish place” resonate with so lots of you? As a result of it’s true! Collectively, we’re all pissed off after working in place for five-plus years, and by recognizing the issue, hopefully, some cages are rattled and optimistic change occurs.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
